Top compounds associated with response to OR4Q3


Feature Type Standardized
Nominal ANOVA
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.046 0.2
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.043 0.2
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.2
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.039 0.2
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.044 0.2
mRNA piperlongumine CTRPv2 pan-cancer AAC -0.038 0.2
mRNA tamatinib CTRPv2 pan-cancer AAC -0.044 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.2
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.04 0.2
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC -0.044 0.2
Download CSV